Paclitaxel - from Taxus brevifolia, powder

View pricing for: Americas/Asia, Europe, Taiwan
Catalog No. Packaging Size Price Quantity
25691-1 1 mg
25691-5 5 mg
25691-25 25 mg


Paclitaxel is a drug used to treat breast cancer and ovarian cancer. It is also being studied in the treatment of other types of cancer. Polysciences offers Paclitaxel extracted from the bark of the Pacific yew tree Taxus brevifolia for research purposes only.

Research on paclitaxel remains a robust area of research. For example, Stone, et al have studied polymer-based Paclitaxel eluting stents for coronary artery disease and found that the Paclitaxel eluting stent markedly reduced the of clinical and angiographic restenosis1.

In addition, Le Broc-Ryckewaert, et al are developing paclitaxel-loaded PLGA nanoparticles in an attempt to minimize the negative side effects of paclitaxel by controlled release from PLGA particles2.

Molecular Weight:
Melting Point:
213° C (dec.)
white powder

1. “A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease”, Gregg W. Stone, et al; N Engl J Med 2004; 350:221-231; January 15, 2004; and Gregg W. Stone, et al, J Am Coll Cardiol Intv. 2013;6(12):1263-1266. 2. “Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells” Le Broc-Ryckewaert, et al; Int J Pharm. 2013 Oct 1;454(2):712-9)

MSDS / Technical Data Sheets / Product Literature